Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 1
1950 2
1953 3
1954 2
1956 1
1957 2
1958 1
1962 2
1963 3
1964 1
1965 1
1966 2
1968 1
1969 1
1971 2
1975 2
1976 1
1977 3
1978 1
1979 1
1980 2
1984 2
1986 1
1987 1
1989 1
1992 1
1993 3
1994 1
1995 3
1996 3
1997 2
1998 3
2000 4
2001 4
2002 3
2003 1
2005 2
2006 1
2007 4
2008 6
2009 4
2010 4
2011 6
2012 8
2013 1
2014 4
2015 2
2016 1
2018 2
2019 1
2020 1
2021 3
2022 2
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Results by year

Filters applied: . Clear all
Page 1
Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model.
von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton Pipkin F, Côté AM, Douglas MJ, Gruslin A, Hutcheon JA, Joseph KS, Kyle PM, Lee T, Loughna P, Menzies JM, Merialdi M, Millman AL, Moore MP, Moutquin JM, Ouellet AB, Smith GN, Walker JJ, Walley KR, Walters BN, Widmer M, Lee SK, Russell JA, Magee LA; PIERS Study Group. von Dadelszen P, et al. Lancet. 2011 Jan 15;377(9761):219-27. doi: 10.1016/S0140-6736(10)61351-7. Epub 2010 Dec 23. Lancet. 2011. PMID: 21185591 Free article. Clinical Trial.
Machine learning-enabled maternal risk assessment for women with pre-eclampsia (the PIERS-ML model): a modelling study.
Montgomery-Csobán T, Kavanagh K, Murray P, Robertson C, Barry SJE, Vivian Ukah U, Payne BA, Nicolaides KH, Syngelaki A, Ionescu O, Akolekar R, Hutcheon JA, Magee LA, von Dadelszen P; PIERS Consortium. Montgomery-Csobán T, et al. Lancet Digit Health. 2024 Apr;6(4):e238-e250. doi: 10.1016/S2589-7500(23)00267-4. Lancet Digit Health. 2024. PMID: 38519152 Free PMC article.
Novel non-invasive protein and peptide drug delivery approaches.
Wallis L, Kleynhans E, Toit TD, Gouws C, Steyn D, Steenekamp J, Viljoen J, Hamman J. Wallis L, et al. Among authors: steyn d. Protein Pept Lett. 2014;21(11):1087-101. doi: 10.2174/0929866521666140807112148. Protein Pept Lett. 2014. PMID: 25106909 Review.
Herbal hepatotoxicity: current status, examples, and challenges.
Calitz C, du Plessis L, Gouws C, Steyn D, Steenekamp J, Muller C, Hamman S. Calitz C, et al. Among authors: steyn d. Expert Opin Drug Metab Toxicol. 2015;11(10):1551-65. doi: 10.1517/17425255.2015.1064110. Epub 2015 Jul 6. Expert Opin Drug Metab Toxicol. 2015. PMID: 26149408 Review.
Treatments for breast abscesses in breastfeeding women.
Irusen H, Rohwer AC, Steyn DW, Young T. Irusen H, et al. Among authors: steyn dw. Cochrane Database Syst Rev. 2015 Aug 17;2015(8):CD010490. doi: 10.1002/14651858.CD010490.pub2. Cochrane Database Syst Rev. 2015. PMID: 26279276 Free PMC article. Review.
Low-dose dopamine for women with severe pre-eclampsia.
Steyn DW, Steyn P. Steyn DW, et al. Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD003515. doi: 10.1002/14651858.CD003515.pub2. Cochrane Database Syst Rev. 2007. PMID: 17253491 Free PMC article. Review.
117 results